EIF4E and lymphoma: Enhanced eIF4E phosphorylation has been observed in various solid tumors and lymphomas, and p-eIF4E overexpression is correlated with poor prognosis or recurrence, metastases in human tumors [10], [13], [24], [27]–[31].